Global and India Sodium Channel Blockers Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and India Sodium Channel Blockers Market Report & Forecast 2024-2034
Sodium Channel Blockers are a class of drugs that selectively block sodium channels and inhibit the influx of sodium ions. The degree of drug blocking of sodium channels is related to heart rate, membrane potential of cardiomyocytes and the reactivation time constant of the channel.
The global Sodium Channel Blockers revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In India, the Sodium Channel Blockers revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of Sodium Channel Blockers include SK biopharmaceuticals, Biogen, Parion Sciences, AlphaNavi Pharma, WEX, Vertex Pharmaceuticals, RaQualia Pharma and KBP Biosciences, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Sodium Channel Blockers market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Sodium Channel Blockers will continue to grow rapidly in the future.
Global Sodium Channel Blockers Scope and Market Size
Sodium Channel Blockers market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Sodium Channel Blockers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Sodium Channel Blockers market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
SK biopharmaceuticals
Biogen
Parion Sciences
AlphaNavi Pharma
WEX
Vertex Pharmaceuticals
RaQualia Pharma
KBP Biosciences
Segment by Type
Class IA (Quinidine, Procainamide, etc.)
Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
Class IC (Propafenone, Flecainide, etc.)
Injection
Oral
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Sodium Channel Blockers definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Sodium Channel Blockers companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Sodium Channel Blockers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sodium Channel Blockers sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
The global Sodium Channel Blockers revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In India, the Sodium Channel Blockers revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of Sodium Channel Blockers include SK biopharmaceuticals, Biogen, Parion Sciences, AlphaNavi Pharma, WEX, Vertex Pharmaceuticals, RaQualia Pharma and KBP Biosciences, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Sodium Channel Blockers market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Sodium Channel Blockers will continue to grow rapidly in the future.
Global Sodium Channel Blockers Scope and Market Size
Sodium Channel Blockers market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Sodium Channel Blockers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Sodium Channel Blockers market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.
By Company
SK biopharmaceuticals
Biogen
Parion Sciences
AlphaNavi Pharma
WEX
Vertex Pharmaceuticals
RaQualia Pharma
KBP Biosciences
Segment by Type
Class IA (Quinidine, Procainamide, etc.)
Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
Class IC (Propafenone, Flecainide, etc.)
Segment by Application
Injection
Oral
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Sodium Channel Blockers definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Sodium Channel Blockers companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Sodium Channel Blockers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sodium Channel Blockers sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices